000			02020 a2200637 4500
005			20250517105117.0
264		0	_c20171214
008			201712s 0 0 eng d
022			_a1476-5365
024	7		_a10.1038/bmt.2016.188 _2doi
040			_aNLM _beng _cNLM
100	1		_aMagenau, J
245	0	0	_aA multicenter trial of myeloablative clofarabine and busulfan conditioning for relapsed or primary induction failure AML not in remission at the time of allogeneic hematopoietic stem cell transplantation. _h[electronic resource]
260			_bBone marrow transplantation _cJan 2017
300			_a59-65 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Multicenter Study
650	0	4	_aAdenine Nucleotides _xadministration & dosage
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAllografts
650	0	4	_aArabinonucleosides _xadministration & dosage
650	0	4	_aBusulfan _xadministration & dosage
650	0	4	_aClofarabine
650	0	4	_aDisease-Free Survival
650	0	4	_aFemale
650	0	4	_aHematopoietic Stem Cell Transplantation
650	0	4	_aHumans
650	0	4	_aInduction Chemotherapy
650	0	4	_aLeukemia, Myeloid, Acute _xmortality
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aSurvival Rate
650	0	4	_aTransplantation Conditioning
700	1		_aWestervelt, P
700	1		_aKhaled, S
700	1		_aMcGuirk, J
700	1		_aHari, P
700	1		_aEapen, M
700	1		_aBecker, P S
700	1		_aParkin, B
700	1		_aBraun, T
700	1		_aLogan, B
700	1		_aWang, H
700	1		_aJagasia, M
700	1		_aRowley, S D
700	1		_aKim, D D H
700	1		_aSchechter, T
700	1		_aFrey, N
700	1		_aScott, B
700	1		_aChuray, T
700	1		_aLieland, S
700	1		_aForman, S
700	1		_aMineishi, S
773	0		_tBone marrow transplantation _gvol. 52 _gno. 1 _gp. 59-65
856	4	0	_uhttps://doi.org/10.1038/bmt.2016.188 _zAvailable from publisher's website
999			_c26237113 _d26237113